April 21, 2016—The Rex Griswold Foundation today announced the presentation of $50,000 to the Translational Genomics Research Institute (TGen) to further its scientific investigation into the cause ...
Analyst Robert Mason CFA from Robert W. Baird maintained a Hold rating on MSA Safety (MSA – Research Report) and keeping the price target at $195.00. Robert Mason CFA has given his Hold rating due to ...
MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...